Company intelligence
Dispatch Bio
On a mission to help create a world where all cancer patients can be cured
Biotechnology Research
68 employees
Founded 2022
1 public signals
About Dispatch Bio
Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform. This novel approach combines the strengths of immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. Dispatch has operations in Philadelphia and San Francisco, with access to world-class researchers.
Verified activity
Signals from Dispatch Bio
1 published signal